liraglutide semaglutide tirzepatide Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and # liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Liraglutide vs Tirzepatide: Daily Single

At 9mg, the rate was 8.8%

Pregnancy Exposure Registry: There will be a pregnancy exposure registry for women who have taken Zepbound during pregnancy

No matter what you think of the actual rights and details involved, no matter how deeply your libertarian leanings go, this is tone deaf beyond belief

Chanel Robinson spent months fighting with her insurance company via certified snail mail over coverage for the medication

Both Zepbound and Wegovy also have a boxed warning about a possible risk of thyroid cancer

Clinical trials have shown strong weight loss results in adults, but data on nursing individuals and the transfer of the drug into breast milk remain limited